vs
Side-by-side financial comparison of NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $23.3M, roughly 1.8× NORTHERN TECHNOLOGIES INTERNATIONAL CORP). NORTHERN TECHNOLOGIES INTERNATIONAL CORP runs the higher net margin — 1.0% vs -17.2%, a 18.3% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 9.2%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-479.7K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 5.8%).
Maxar Technologies Inc., was an American space technology company, specializing in geospatial intelligence, Earth observation, and on-orbit satellite servicing, satellite products, and related services. DigitalGlobe and MDA Holdings Company merged to become Maxar Technologies on October 5, 2017.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
NTIC vs STIM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.3M | $41.8M |
| Net Profit | $237.8K | $-7.2M |
| Gross Margin | 36.0% | 52.0% |
| Operating Margin | 4.0% | -12.1% |
| Net Margin | 1.0% | -17.2% |
| Revenue YoY | 9.2% | 85.7% |
| Net Profit YoY | -57.6% | 43.2% |
| EPS (diluted) | $0.03 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.3M | $41.8M | ||
| Q3 25 | $22.3M | $37.3M | ||
| Q2 25 | $21.5M | $38.1M | ||
| Q1 25 | $19.1M | $32.0M | ||
| Q4 24 | $21.3M | $22.5M | ||
| Q3 24 | $23.3M | $18.5M | ||
| Q2 24 | $20.7M | $16.4M | ||
| Q1 24 | $20.8M | $17.4M |
| Q4 25 | $237.8K | $-7.2M | ||
| Q3 25 | $-1.1M | $-9.0M | ||
| Q2 25 | $121.8K | $-10.1M | ||
| Q1 25 | $434.3K | $-12.7M | ||
| Q4 24 | $561.1K | $-12.7M | ||
| Q3 24 | $1.8M | $-13.3M | ||
| Q2 24 | $976.6K | $-9.8M | ||
| Q1 24 | $1.7M | $-7.9M |
| Q4 25 | 36.0% | 52.0% | ||
| Q3 25 | 37.9% | 45.9% | ||
| Q2 25 | 38.4% | 46.6% | ||
| Q1 25 | 35.6% | 49.2% | ||
| Q4 24 | 38.3% | 66.2% | ||
| Q3 24 | 43.8% | 75.6% | ||
| Q2 24 | 38.2% | 74.0% | ||
| Q1 24 | 40.0% | 75.1% |
| Q4 25 | 4.0% | -12.1% | ||
| Q3 25 | 4.2% | -19.6% | ||
| Q2 25 | 4.0% | -21.1% | ||
| Q1 25 | -1.7% | -34.4% | ||
| Q4 24 | 5.2% | -51.0% | ||
| Q3 24 | 11.8% | -41.7% | ||
| Q2 24 | 7.4% | -51.7% | ||
| Q1 24 | 10.6% | -39.4% |
| Q4 25 | 1.0% | -17.2% | ||
| Q3 25 | -4.9% | -24.3% | ||
| Q2 25 | 0.6% | -26.6% | ||
| Q1 25 | 2.3% | -39.6% | ||
| Q4 24 | 2.6% | -56.4% | ||
| Q3 24 | 7.9% | -72.0% | ||
| Q2 24 | 4.7% | -59.8% | ||
| Q1 24 | 8.2% | -45.2% |
| Q4 25 | $0.03 | $-0.10 | ||
| Q3 25 | $-0.11 | $-0.13 | ||
| Q2 25 | $0.01 | $-0.15 | ||
| Q1 25 | $0.04 | $-0.21 | ||
| Q4 24 | $0.06 | $-0.34 | ||
| Q3 24 | $0.19 | $-0.44 | ||
| Q2 24 | $0.10 | $-0.33 | ||
| Q1 24 | $0.17 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.4M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $72.4M | $22.4M |
| Total Assets | $104.0M | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $28.1M | ||
| Q3 25 | $7.3M | $28.0M | ||
| Q2 25 | $6.8M | $11.0M | ||
| Q1 25 | $5.1M | $20.2M | ||
| Q4 24 | $5.6M | $18.5M | ||
| Q3 24 | $5.0M | $20.9M | ||
| Q2 24 | $5.8M | $42.6M | ||
| Q1 24 | $4.8M | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M | ||
| Q1 24 | — | $59.4M |
| Q4 25 | $72.4M | $22.4M | ||
| Q3 25 | $72.1M | $27.4M | ||
| Q2 25 | $72.4M | $27.1M | ||
| Q1 25 | $69.7M | $35.5M | ||
| Q4 24 | $70.2M | $27.7M | ||
| Q3 24 | $71.2M | $9.4M | ||
| Q2 24 | $68.9M | $19.4M | ||
| Q1 24 | $68.4M | $27.7M |
| Q4 25 | $104.0M | $141.6M | ||
| Q3 25 | $102.7M | $145.5M | ||
| Q2 25 | $99.3M | $134.7M | ||
| Q1 25 | $93.7M | $142.0M | ||
| Q4 24 | $94.0M | $140.9M | ||
| Q3 24 | $94.7M | — | ||
| Q2 24 | $89.3M | $96.8M | ||
| Q1 24 | $87.3M | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× | ||
| Q1 24 | — | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $341.9K | $908.0K |
| Free Cash FlowOCF − Capex | $-479.7K | $692.0K |
| FCF MarginFCF / Revenue | -2.1% | 1.7% |
| Capex IntensityCapex / Revenue | 3.5% | 0.5% |
| Cash ConversionOCF / Net Profit | 1.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.8M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $341.9K | $908.0K | ||
| Q3 25 | $-1.4M | $-785.0K | ||
| Q2 25 | $609.7K | $-3.5M | ||
| Q1 25 | $803.7K | $-17.0M | ||
| Q4 24 | $2.4M | $-8.6M | ||
| Q3 24 | — | $-5.4M | ||
| Q2 24 | $1.9M | $-5.0M | ||
| Q1 24 | — | $-12.0M |
| Q4 25 | $-479.7K | $692.0K | ||
| Q3 25 | $-1.4M | $-899.0K | ||
| Q2 25 | $-171.2K | $-3.8M | ||
| Q1 25 | $293.1K | $-17.2M | ||
| Q4 24 | $1.2M | $-8.7M | ||
| Q3 24 | — | $-5.8M | ||
| Q2 24 | $869.4K | $-5.6M | ||
| Q1 24 | — | $-12.4M |
| Q4 25 | -2.1% | 1.7% | ||
| Q3 25 | -6.3% | -2.4% | ||
| Q2 25 | -0.8% | -9.9% | ||
| Q1 25 | 1.5% | -53.8% | ||
| Q4 24 | 5.5% | -38.6% | ||
| Q3 24 | — | -31.3% | ||
| Q2 24 | 4.2% | -34.0% | ||
| Q1 24 | — | -71.1% |
| Q4 25 | 3.5% | 0.5% | ||
| Q3 25 | 0.2% | 0.3% | ||
| Q2 25 | 3.6% | 0.7% | ||
| Q1 25 | 2.7% | 0.7% | ||
| Q4 24 | 5.7% | 0.4% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | 5.2% | 3.7% | ||
| Q1 24 | — | 2.2% |
| Q4 25 | 1.44× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.01× | — | ||
| Q1 25 | 1.85× | — | ||
| Q4 24 | 4.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.99× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTIC
| Inside The USA To Unaffiliated Customers | $7.5M | 32% |
| Natur Tec | $6.0M | 26% |
| Acobal | $3.6M | 15% |
| Other | $2.7M | 12% |
| BR | $2.1M | 9% |
| Zerust OY | $1.4M | 6% |
STIM
Segment breakdown not available.
